How to Review State Medical Advertising Rules Before You Publish

There is no durable “state-by-state medical advertising cheat sheet.”

The promise is attractive because the real work is inconvenient. Rules can sit in statutes, administrative codes, medical-board guidance, dental or nursing board materials, consumer-protection law, facility requirements, and enforcement actions. The answer can also change with the license, service, medium, and exact wording of a claim.

A static article that appears to summarize all fifty states would need continuous legal review to remain dependable. This is not that article. It is a process for finding the right sources, asking better questions, and knowing when a marketing team should stop and involve counsel.

Begin with five facts

Before looking for a rule, define the jurisdiction, license, service, audience, and claim.

Jurisdiction is not simply the address in the footer. A campaign may reach people in another state or promote telehealth across state lines. License means identifying every regulated professional and entity represented, including whether different boards govern physicians, dentists, advanced-practice clinicians, behavioral-health professionals, or facilities. Service matters because surgery, aesthetics, reproductive care, weight management, and other categories can carry distinct requirements. Audience and channel affect how the message is received. Finally, the exact claim matters: “board certified,” “specialist,” “safe,” a patient testimonial, a price, and a before-and-after image raise different questions.

Without those facts, “Is this ad compliant?” is too vague to answer responsibly.

Build a source file, not a collection of search results

The Federation of State Medical Boards maintains a directory of state medical and osteopathic boards. It is a useful starting point, not a substitute for the governing law.

For each relevant jurisdiction and license type, save the current primary materials: the practice act or statute, administrative rules, official board guidance, and recent board notices or disciplinary material when relevant. Record the source URL, the section, the date accessed, and the person who reviewed it. Search snippets, law-firm summaries, and old slide decks may point toward an issue, but they should not be the final authority.

The marketing file should also contain the proposed advertisement, landing page, targeting settings, images, substantiation for objective claims, releases or authorizations, and the final approval. The data-use portion belongs in the same review as the practice’s HIPAA marketing fundamentals. That record makes later review possible when a campaign changes or a rule is updated.

Why exact language changes the answer

California offers a useful example. The Medical Board of California explains that physicians may advertise specialization, but the phrase “board certified” is restricted to certifications that meet criteria in California Business and Professions Code section 651. The Board’s current practice information describes the permitted certification categories and directs readers to the statute.

That distinction is easy to flatten into the wrong rule. “Specializes in” and “board certified in” are not interchangeable. Nor should California’s formulation be assumed to apply in Texas, Florida, or any other state.

The same precision is needed for testimonials and result imagery. A consent form answers whether a patient authorized a use; it does not prove that the advertisement’s overall impression is representative or supported. The same distinction shapes responsible before-and-after photo review. A “results vary” line does not rescue a misleading result claim. Federal advertising principles, state professional rules, privacy law, and platform policies may all be relevant.

A worked review: a multi-state aesthetic campaign

Suppose a group wants to run an ad that says, “Board-certified cosmetic experts. Transform your body in one visit,” accompanied by a dramatic before-and-after image. The campaign targets three states and links to a shared landing page.

A useful review separates the problems instead of asking for a blanket approval. Who holds which certification, and may each clinician use “board certified” in that form in each jurisdiction? Does “expert” imply a credential or level of superiority that needs support? Does “one visit” describe the procedure or promise a result? Is the result image authentic, consistently produced, authorized for this use, and presented with enough context to avoid suggesting a typical outcome? Does the landing page name the treating entity and location clearly? Do targeting settings offer services only where the practice and clinicians may provide them?

The group may end with different creative by state, a narrower shared claim, or no campaign at all. “Use the strictest state’s rule everywhere” can be operationally convenient, but it is not a universal legal solution. Rules sometimes require different affirmative disclosures rather than simply more conservative language.

Create a risk-based review lane

Not every appointment-hours update needs outside counsel. Not every clinical claim should be published after an internal copy edit. Define which content follows routine review and which content automatically escalates.

A sensible escalation list includes:

• New claims about outcomes, safety, superiority, speed, permanence, or typical results.
• “Board certified,” “specialist,” “expert,” and other credential language.
• Testimonials, endorsements, influencer content, patient images, and before-and-after galleries.
• Prices, financing, “free” offers, guarantees, and limited-time promotions.
• Controlled-substance, prescription, device, or off-label-related promotion.
• New states, license types, facilities, service lines, or telehealth markets.
• Any campaign responding to a complaint, investigation, or prior enforcement concern.

Give the reviewer the complete asset and the intended distribution. The FTC and FDA divide is one part of that analysis, not a substitute for state and professional rules. A headline viewed alone can look harmless while the image, targeting, button, and landing page create a different overall impression.

Review dates matter more than boilerplate

“Compliant as of publication” is not a shield, but an as-of date makes the research honest. Establish a review interval based on risk and a change trigger for new laws, board notices, platform rules, service lines, clinicians, certifications, and geographic expansion.

The process owner should be able to answer four questions: Which primary sources did we check? What facts did we rely on? Who approved the judgment? What change would force a new review?

Marketing teams do not need to become a fifty-state law firm. They do need to stop treating compliance as a final disclaimer pasted onto finished creative. The responsible approach begins earlier: define the facts, find the governing sources, narrow the claim, preserve the record, and escalate the decisions that require legal judgment.

---

This article provides general educational information, not legal advice. Laws and board rules change, and their application depends on specific facts. Have qualified healthcare counsel review material claims and multi-state campaigns before publication.